Lisa Stanick, MBA

The American College of Chest Physicians (CHEST) recently launched the inaugural Oncology PREP (Professional Representative Education Program) clinical immersion program. This PREP was developed by CHEST Enterprises under an exclusive licensing arrangement with the American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing physicians who care for people with cancer. The first Oncology PREP curriculum is focused on metastatic castration-resistant prostate cancer and is being conducted for sales representatives from a leading pharmaceutical company.

Oncology PREP is designed for pharmaceutical sales representatives to bolster their knowledge of best practices and innovative advances in oncology care in an effort to equip them to make informed contributions to discussions of disease management and patient care. Multidisciplinary teams at leading cancer centers, selected by CHEST, teach the patient-focused curriculum. Industry customers have no input into the content of the curriculum to ensure a completely unbiased educational experience for representatives.

General topics in each Oncology PREP course include risk factors, screening techniques, the latest procedures used in diagnosis and staging, treatment options and care management, and the evolving use of biomarkers. Participants also engage in patient simulation cases and panel discussions.

“CHEST has been offering this program for over 10 years in the pulmonary disease area, and we are proud to apply the success of that program to launch the first Oncology PREP clinical immersion program,” said John C. Alexander Jr., MD, President, CHEST Enterprises Board of Directors. “Our team is honored to work with ASCO to launch this program to address the needs of prostate cancer clinicians, sales representatives, and, ultimately, patients.”

In January 2015, a select group of sales leaders from the pharmaceutical company participated in a pilot program taught by a team of oncologists and urologists. Courses for field representatives are currently being conducted at prominent cancer centers. Participants who successfully complete the program will receive an assessment-based certification of completion valid for 3 years.

In addition to CHEST PREP and Oncology PREP programs, CHEST has agreements with the American Congress of Obstetricians and Gynecologists (ACOG) and the Society of Interventional Radiology (SIR) to develop and conduct PREP clinical immersion programs in the areas of women’s health and interventional radiology.If you would like more information about these exciting PREP programs and the opportunity to develop curriculum content or participate as faculty, or if you would like to find out how your hospital or medical center can become a course site, please contact Lisa Stanick, Director – PREP Operations, at [email protected] or 224/521-9518.

The American College of Chest Physicians (CHEST) recently launched the inaugural Oncology PREP (Professional Representative Education Program) clinical immersion program. This PREP was developed by CHEST Enterprises under an exclusive licensing arrangement with the American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing physicians who care for people with cancer. The first Oncology PREP curriculum is focused on metastatic castration-resistant prostate cancer and is being conducted for sales representatives from a leading pharmaceutical company.

Oncology PREP is designed for pharmaceutical sales representatives to bolster their knowledge of best practices and innovative advances in oncology care in an effort to equip them to make informed contributions to discussions of disease management and patient care. Multidisciplinary teams at leading cancer centers, selected by CHEST, teach the patient-focused curriculum. Industry customers have no input into the content of the curriculum to ensure a completely unbiased educational experience for representatives.

General topics in each Oncology PREP course include risk factors, screening techniques, the latest procedures used in diagnosis and staging, treatment options and care management, and the evolving use of biomarkers. Participants also engage in patient simulation cases and panel discussions.

“CHEST has been offering this program for over 10 years in the pulmonary disease area, and we are proud to apply the success of that program to launch the first Oncology PREP clinical immersion program,” said John C. Alexander Jr., MD, President, CHEST Enterprises Board of Directors. “Our team is honored to work with ASCO to launch this program to address the needs of prostate cancer clinicians, sales representatives, and, ultimately, patients.”

In January 2015, a select group of sales leaders from the pharmaceutical company participated in a pilot program taught by a team of oncologists and urologists. Courses for field representatives are currently being conducted at prominent cancer centers. Participants who successfully complete the program will receive an assessment-based certification of completion valid for 3 years.

In addition to CHEST PREP and Oncology PREP programs, CHEST has agreements with the American Congress of Obstetricians and Gynecologists (ACOG) and the Society of Interventional Radiology (SIR) to develop and conduct PREP clinical immersion programs in the areas of women’s health and interventional radiology.If you would like more information about these exciting PREP programs and the opportunity to develop curriculum content or participate as faculty, or if you would like to find out how your hospital or medical center can become a course site, please contact Lisa Stanick, Director – PREP Operations, at [email protected] or 224/521-9518.

The American College of Chest Physicians (CHEST) recently launched the inaugural Oncology PREP (Professional Representative Education Program) clinical immersion program. This PREP was developed by CHEST Enterprises under an exclusive licensing arrangement with the American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing physicians who care for people with cancer. The first Oncology PREP curriculum is focused on metastatic castration-resistant prostate cancer and is being conducted for sales representatives from a leading pharmaceutical company.

Oncology PREP is designed for pharmaceutical sales representatives to bolster their knowledge of best practices and innovative advances in oncology care in an effort to equip them to make informed contributions to discussions of disease management and patient care. Multidisciplinary teams at leading cancer centers, selected by CHEST, teach the patient-focused curriculum. Industry customers have no input into the content of the curriculum to ensure a completely unbiased educational experience for representatives.

General topics in each Oncology PREP course include risk factors, screening techniques, the latest procedures used in diagnosis and staging, treatment options and care management, and the evolving use of biomarkers. Participants also engage in patient simulation cases and panel discussions.

“CHEST has been offering this program for over 10 years in the pulmonary disease area, and we are proud to apply the success of that program to launch the first Oncology PREP clinical immersion program,” said John C. Alexander Jr., MD, President, CHEST Enterprises Board of Directors. “Our team is honored to work with ASCO to launch this program to address the needs of prostate cancer clinicians, sales representatives, and, ultimately, patients.”

In January 2015, a select group of sales leaders from the pharmaceutical company participated in a pilot program taught by a team of oncologists and urologists. Courses for field representatives are currently being conducted at prominent cancer centers. Participants who successfully complete the program will receive an assessment-based certification of completion valid for 3 years.

In addition to CHEST PREP and Oncology PREP programs, CHEST has agreements with the American Congress of Obstetricians and Gynecologists (ACOG) and the Society of Interventional Radiology (SIR) to develop and conduct PREP clinical immersion programs in the areas of women’s health and interventional radiology.If you would like more information about these exciting PREP programs and the opportunity to develop curriculum content or participate as faculty, or if you would like to find out how your hospital or medical center can become a course site, please contact Lisa Stanick, Director – PREP Operations, at [email protected] or 224/521-9518.

Did you know the American College of Chest Physicians (CHEST) has provided disease-state-specific education for pharmaceutical and medical device representatives for more than 12 years?

The CHEST Professional Representative Education Program, or PREP, is an unbranded disease-state clinical immersion program. The PREP Team works with pharmaceutical and medical device companies to understand their learning objectives and the educational needs of their representatives. We then develop a customized program to address those specific needs. Each program uses different learning methods—problem-based case studies, patient testimony, simulation, and faculty-led workshops—to create a dynamic learning environment that increases interaction and develops deeper comprehension. The PREP curriculum is based on evidence-based clinical practice guidelines and consensus statements. Each program is created by clinical thought leaders and delivered by expert faculty, typically drawn from our CHEST membership. PREP courses are held at leading hospitals and academic medical centers throughout the country, as well as the CHEST Innovation, Simulation, and Training Center in Glenview, Illinois.

Participants, who successfully complete the course objectives, including the post-course knowledge assessment, are awarded a Certificate of Completion valid for a 3-year period.

More importantly, they gain the most current, in-depth clinical information needed to engage with health-care professionals—knowledgeably, confidently, and meaningfully. This translates to better-educated representatives who interact with you as you make clinical decisions that enhance patient outcomes.

CHEST has trained over 4,000 sales representatives over the past 2 years. Not only has CHEST conducted PREP programs for disease states such as atrial fibrillation, venous thromboembolism (VTE), and COPD, PREP programs are also available for women’s health, oncology, and interventional radiology through strategic agreements with the American Congress of Obstetricians and Gynecologists (ACOG), the American Society of Clinical Oncology (ASCO), and the Society of Interventional Radiology (SIR).

The PREP Team recently conducted a very successful Prostate Cancer PREP course at Huntsman Cancer Institute in Salt Lake City, Utah. This course is the first of four to be conducted over the next few months at academic medical centers around the country. Over 100 pharmaceutical sales representatives will participate in this PREP, which was developed and is being conducted through CHEST’s agreement with ASCO.

There are several exciting opportunities coming up in the next few months, as the PREP Team continues to expand the PREP offerings to meet the needs of the industry.

If you would like to develop curriculum content or participate as faculty for a PREP course or to receive more information about how your hospital or medical center can become a course site, please contact me at [email protected] or 224/521-9518.

Did you know the American College of Chest Physicians (CHEST) has provided disease-state-specific education for pharmaceutical and medical device representatives for more than 12 years?

The CHEST Professional Representative Education Program, or PREP, is an unbranded disease-state clinical immersion program. The PREP Team works with pharmaceutical and medical device companies to understand their learning objectives and the educational needs of their representatives. We then develop a customized program to address those specific needs. Each program uses different learning methods—problem-based case studies, patient testimony, simulation, and faculty-led workshops—to create a dynamic learning environment that increases interaction and develops deeper comprehension. The PREP curriculum is based on evidence-based clinical practice guidelines and consensus statements. Each program is created by clinical thought leaders and delivered by expert faculty, typically drawn from our CHEST membership. PREP courses are held at leading hospitals and academic medical centers throughout the country, as well as the CHEST Innovation, Simulation, and Training Center in Glenview, Illinois.

Participants, who successfully complete the course objectives, including the post-course knowledge assessment, are awarded a Certificate of Completion valid for a 3-year period.

More importantly, they gain the most current, in-depth clinical information needed to engage with health-care professionals—knowledgeably, confidently, and meaningfully. This translates to better-educated representatives who interact with you as you make clinical decisions that enhance patient outcomes.

CHEST has trained over 4,000 sales representatives over the past 2 years. Not only has CHEST conducted PREP programs for disease states such as atrial fibrillation, venous thromboembolism (VTE), and COPD, PREP programs are also available for women’s health, oncology, and interventional radiology through strategic agreements with the American Congress of Obstetricians and Gynecologists (ACOG), the American Society of Clinical Oncology (ASCO), and the Society of Interventional Radiology (SIR).

The PREP Team recently conducted a very successful Prostate Cancer PREP course at Huntsman Cancer Institute in Salt Lake City, Utah. This course is the first of four to be conducted over the next few months at academic medical centers around the country. Over 100 pharmaceutical sales representatives will participate in this PREP, which was developed and is being conducted through CHEST’s agreement with ASCO.

There are several exciting opportunities coming up in the next few months, as the PREP Team continues to expand the PREP offerings to meet the needs of the industry.

If you would like to develop curriculum content or participate as faculty for a PREP course or to receive more information about how your hospital or medical center can become a course site, please contact me at [email protected] or 224/521-9518.

Did you know the American College of Chest Physicians (CHEST) has provided disease-state-specific education for pharmaceutical and medical device representatives for more than 12 years?

The CHEST Professional Representative Education Program, or PREP, is an unbranded disease-state clinical immersion program. The PREP Team works with pharmaceutical and medical device companies to understand their learning objectives and the educational needs of their representatives. We then develop a customized program to address those specific needs. Each program uses different learning methods—problem-based case studies, patient testimony, simulation, and faculty-led workshops—to create a dynamic learning environment that increases interaction and develops deeper comprehension. The PREP curriculum is based on evidence-based clinical practice guidelines and consensus statements. Each program is created by clinical thought leaders and delivered by expert faculty, typically drawn from our CHEST membership. PREP courses are held at leading hospitals and academic medical centers throughout the country, as well as the CHEST Innovation, Simulation, and Training Center in Glenview, Illinois.

Participants, who successfully complete the course objectives, including the post-course knowledge assessment, are awarded a Certificate of Completion valid for a 3-year period.

More importantly, they gain the most current, in-depth clinical information needed to engage with health-care professionals—knowledgeably, confidently, and meaningfully. This translates to better-educated representatives who interact with you as you make clinical decisions that enhance patient outcomes.

CHEST has trained over 4,000 sales representatives over the past 2 years. Not only has CHEST conducted PREP programs for disease states such as atrial fibrillation, venous thromboembolism (VTE), and COPD, PREP programs are also available for women’s health, oncology, and interventional radiology through strategic agreements with the American Congress of Obstetricians and Gynecologists (ACOG), the American Society of Clinical Oncology (ASCO), and the Society of Interventional Radiology (SIR).

The PREP Team recently conducted a very successful Prostate Cancer PREP course at Huntsman Cancer Institute in Salt Lake City, Utah. This course is the first of four to be conducted over the next few months at academic medical centers around the country. Over 100 pharmaceutical sales representatives will participate in this PREP, which was developed and is being conducted through CHEST’s agreement with ASCO.

There are several exciting opportunities coming up in the next few months, as the PREP Team continues to expand the PREP offerings to meet the needs of the industry.

If you would like to develop curriculum content or participate as faculty for a PREP course or to receive more information about how your hospital or medical center can become a course site, please contact me at [email protected] or 224/521-9518.